Skip to main content
Equibles
CTRE logo

CTRE · CareTrust REIT, Inc.

Track CTRE — free

Use CTRE with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CTRE

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$39.82 +0.52 (+1.32%) At close · Aug 19
Market Cap
$9.32B
Shares
236.29M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$39.82 Open$39.60 Day$39.32–39.86 52W close$32.90–43.40 Avg vol 30d2.3M Short int24.3M · 10.3% float · 11.4d Short vol53% Last earningsAug 7, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 6, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 6, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Neutral
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Low
      Market backdrop VIX 14.9 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg +3%
      above
      Price vs 50-day avg −1%
      below
      RSI (14) 45
      neutral
      MACD trend Negative
      52-week position 66%
      mid-range
      Momentum
      relative strength
      Weak
      1-month return −6%
      trailing
      6-month return −3%
      trailing
      YTD return +10%
      this year
      Relative strength −15%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $40 › 200d $39 — 50d above 200d
      Institutional flow Accumulating
      +6% holders QoQ · +78 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      10.28% of float · ▲ +1.9% MoM · 11.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      510 holders — near 3-yr high, broad support
      Squeeze score 76
      high risk · 0–100
      Fundamentals
      Excellent
      Revenue growth +61%
      Y/Y
      EPS growth +96%
      Y/Y
      Free cash flow $391.1M
      Valuation P/E 24.5
      below peers
      Buyback $150.0M
      remaining
      Balance sheet $399.1M
      net debt
      Quant / Vol
      risk profile
      Low
      Volatility 25%
      annualized · 1-yr
      Max drawdown −14%
      past year
      ATR 2.4%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 6, 2026
      Interest income from financing receivables · FY2026 Initiated $43M
      Prior guidance period ended · from the 8-K filed Nov 5, 2025
      Net income · 2025 $1.41 – $1.42
      Normalized FFO · 2025 $1.76 – $1.77
      Normalized FAD · 2025 $1.76 – $1.77

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +3% Bullish
      Price vs 50-day avg
      −1% Neutral
      RSI (14)
      45 Neutral
      MACD trend
      Negative Bearish
      52-week position
      66% Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $40 › 200d $39 — 50d above 200d
      Institutional flow Accumulating
      +6% holders QoQ · +78 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      10.28% of float · ▲ +1.9% MoM · 11.4 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      510 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $33 Now $40 · 66% Range high $43
      vs 200-day avg +3% vs 50-day avg -1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Annualized Normalized Run Rate EBITDA attributable to CareTrust REIT, Inc. non-GAAP 579.31M Q2 2026 —
      Blended stabilized yield 8.9% Q2 2026 —
      Contractual rent and interest collection 100% Q2 2026 —
      Gross asset value 6.55B Q2'26 —
      Gross proceeds from ATM offering 363.58M Q2'26 —
      Gross proceeds from forward equity offering $578.2M Q2 2026 —
      Investment activity $899.6M Q2 2026 —
      Net debt 583.78M Q2'26 —
      Normalized EBITDA attributable to CareTrust REIT, Inc. non-GAAP 140.69M Q2 2026 —
      Normalized FAD per share attributable to CareTrust REIT, Inc. non-GAAP $0.99 Six Months Ended June 30, 2026 —
      Normalized FFO per share attributable to CareTrust REIT, Inc. non-GAAP $0.99 Six Months Ended June 30, 2026 —
      Normalized Run Rate EBITDA attributable to CareTrust REIT, Inc. non-GAAP 144.83M Q2 2026 —
      GAAP → non-GAAP reconciliation
      GAAP Normalized EBITDA attributable to CareTrust REIT, Inc. $140.69M
      +$4.14M Full impact of quarterly investments
      = Normalized Run Rate EBITDA attributable to CareTrust REIT, Inc. $144.83M
      Investment activity (closed during quarter) $245.1M first quarter ended March 31, 2026 —
      Net Debt to Annualized Normalized Run Rate EBITDA non-GAAP 0.6 first quarter ended March 31, 2026 —
      Gross proceeds raised through equity issuances $1.1B Full year 2025 —
      Investment activity closed $1.8B Full year 2025 —
      Net Debt to Annualized Normalized Run Rate EBITDA attributable to CareTrust REIT, Inc. non-GAAP 0.7 Three Months Ended December 31, 2025 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      REIT - Healthcare Facilities — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      CTRE
      CareTrust REIT, Inc.
      this stock
      		$9.32B +10.1% +60.8% 24.5 10.3%
      WELL
      Welltower Inc.
      		 $166.20B +27.0% +35.6% 117.1 2.5%
      VTR
      Ventas, Inc.
      		 $46.78B +18.7% +18.5% 168.9 4.6%
      DOC
      Healthpeak Properties, Inc.
      		 $14.24B +29.1% +4.5% 59.0 3.5%
      OHI
      Omega Healthcare Investors Inc
      		 $14.11B +5.8% +13.2% 16.6 4.2%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      510
      % held
      105.9%
      Net QoQ
      +52.0M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      507
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      24.3M
      Days to cover
      11.4d
      Change
      +447.3K sh
      View
      Short Volume
      Short vol %
      53%
      As of
      Aug 19, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      5.2K
      Value
      $222.8K
      As of
      Jul 29, 2026
      View
      Off-Exchange
      Off-exchange %
      40.9%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Sell
      Member
      Daniel Goldman
      Amount
      $1.0K–$15.0K
      Traded
      Jul 12, 2023
      View
      Financials
      Financials
      Revenue (FY)
      $476.4M
      Net income (FY)
      $320.5M
      EPS diluted
      $1.57
      View
      Buybacks
      Authorized
      $150.0M
      Remaining
      $150.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 6, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $1.0M
      Shares
      35.0K
      Filed
      Sep 4, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 7, 2026
      View
      Investor Relations
      Latest news
      CareTrust Announces $291 Million…
      Published
      Aug 6, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      CTRE +1.7% -6.0% -3.2% -5.1% +10.1%
      SPY -0.4% +2.9% +11.6% +3.0% +12.8%
      vs SPY +2.1% -8.9% -14.8% -8.0% -2.7%

      Capital returns

      Latest dividend
      $0.39 / share · ex Jun 30, 2026
      Raised 16.4%
      Paid (TTM)
      $1.45 / share · 4 payouts
      Dividend yield (TTM, derived)
      3.64%
      Buyback program · as of Sep 30, 2022
      Authorized
      $150.00M
      Spent (derived)
      $0
      Remaining
      $150.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 1590717 CUSIP 14174T107 13F (30d) 461 filings 454 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)